title: Alternatives to indicating roflumilast and the chronic obstructive pulmonary disease classification.
authors.forename: Luis M
authors.initials: LM
authors.lastname: Blasco
mesh_terms: D000631:Aminopyridines / Q000494:pharmacology / Q000627:therapeutic use*; D015551:Autoimmunity; D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D015897:Comorbidity; D003521:Cyclopropanes / Q000494:pharmacology / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D016867:Immunocompromised Host; D017053:Infection Control; D007249:Inflammation; D058988:Phosphodiesterase 4 Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000145:classification* / Q000188:drug therapy / Q000276:immunology; D012907:Smoking / Q000009:adverse effects / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000631:Aminopyridines; D001549:Benzamides; D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D003521:Cyclopropanes; D058988:Phosphodiesterase 4 Inhibitors; D014409:Tumor Necrosis Factor-alpha; C424423:Roflumilast